Gambia Cough Syrup Deaths

India will take "appropriate action" after completing an investigation into a complaint that a drug regulator helped switch samples of cough syrup linked to the death of children in Gambia in return for a bribe, two officials said on Wednesday.

Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or

Cough syrup from a Haryana-based firm that allegedly caused deaths of children in Gambia, has passed all tests, sources in Union Health Ministry told NDTV today.

Gambia's government is "far advanced" in exploring avenues for potential legal action against Atlantic Pharmaceuticals and Maiden Pharmaceuticals over toxic cough syrups that were imported from India, it said on Friday.

A joint probe by the Centers for Disease Control and Prevention (CDC) of the US and the Gambian health authorities has suggested a strong link between the death of many children in Gambia and the consumption of made-in-India cough syrups that were al

Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.

Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia

The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country died after taking an Indian-made cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.

Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup.

The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.

Maiden Pharmaceuticals Ltd will seek clearance to re-open its factory after agovernment laboratory found nothing wrong in samples taken from syrups that the World Health Organisation (WHO) had suspected of being linked to children' deaths in Gambia

The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.

Cough syrup samples of Maiden Pharmaceuticals have been found to be of standard quality, the government has told Parliament.

Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.

India will take "appropriate action" after completing an investigation into a complaint that a drug regulator helped switch samples of cough syrup linked to the death of children in Gambia in return for a bribe, two officials said on Wednesday.

Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or

Cough syrup from a Haryana-based firm that allegedly caused deaths of children in Gambia, has passed all tests, sources in Union Health Ministry told NDTV today.

Gambia's government is "far advanced" in exploring avenues for potential legal action against Atlantic Pharmaceuticals and Maiden Pharmaceuticals over toxic cough syrups that were imported from India, it said on Friday.

A joint probe by the Centers for Disease Control and Prevention (CDC) of the US and the Gambian health authorities has suggested a strong link between the death of many children in Gambia and the consumption of made-in-India cough syrups that were al

Two pharmaceutical company executives have been sentenced to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia, reported Reuters.

Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia

The Centre today said it is in touch with Uzbekistan after it alleged 18 children in the country died after taking an Indian-made cough syrup. An investigation is in progress and the manufacturing of the cough syrup has been stopped.

Uzbekistan has claimed that at least 18 children in the country have died after allegedly taking an India-manufactured cough syrup.

The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.

Maiden Pharmaceuticals Ltd will seek clearance to re-open its factory after agovernment laboratory found nothing wrong in samples taken from syrups that the World Health Organisation (WHO) had suspected of being linked to children' deaths in Gambia

The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe.

Cough syrup samples of Maiden Pharmaceuticals have been found to be of standard quality, the government has told Parliament.

Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue.